{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:58:02Z","timestamp":1762271882538},"reference-count":48,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2015,3,5]],"date-time":"2015-03-05T00:00:00Z","timestamp":1425513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00005-015-0333-2","type":"journal-article","created":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T14:51:26Z","timestamp":1425480686000},"page":"305-315","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A Targeted Multiple Antigenic Peptide Vaccine Augments the Immune Response to Self TGF-\u03b21 and Suppresses Ongoing Hepatic Fibrosis"],"prefix":"10.2478","volume":"63","author":[{"given":"Yaping","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiufang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangsuo","family":"Dang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2015,3,5]]},"reference":[{"key":"333_CR1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Invest 115:209\u2013218","journal-title":"J Clin Invest"},{"key":"333_CR2","volume-title":"Peptide-based vaccines, handbook of cancer vaccines","author":"CM Berger","year":"2004","unstructured":"Berger CM, Knutson KL, Salazar LG et al (2004) Peptide-based vaccines, handbook of cancer vaccines. Humana Press Inc, Totowa"},{"key":"333_CR3","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1517\/13543770903397400","volume":"19","author":"D Bonafoux","year":"2009","unstructured":"Bonafoux D, Lee WC (2009) Strategies for TGF-beta modulation: a review of recent patents. Expert Opin Ther Pat 19:1759\u20131769","journal-title":"Expert Opin Ther Pat"},{"key":"333_CR4","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S1286-4579(99)00250-6","volume":"1","author":"MH Branton","year":"1999","unstructured":"Branton MH, Kopp JB (1999) TGF-beta and fibrosis. Microbes Infect 1:1349\u20131365","journal-title":"Microbes Infect"},{"key":"333_CR5","first-page":"50","volume":"10","author":"KK Cassidy Brady","year":"2012","unstructured":"Cassidy Brady KK, Taylor W, Patkar A et al (2012) Carrier protein outsourcing. BioProcess Int 10:50\u201355","journal-title":"BioProcess Int"},{"key":"333_CR6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1172\/JCI11849","volume":"108","author":"B Chackerian","year":"2001","unstructured":"Chackerian B, Lowy DR, Schiller JT (2001) Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies. J Clin Invest 108:415\u2013423","journal-title":"J Clin Invest"},{"key":"333_CR7","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1021\/mp9000469","volume":"6","author":"K Cheng","year":"2009","unstructured":"Cheng K, Yang N, Mahato RI (2009) TGF-beta1 gene silencing for treating liver fibrosis. Mol Pharm 6:772\u2013779","journal-title":"Mol Pharm"},{"key":"333_CR8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00262-004-0576-y","volume":"54","author":"MJ Ciesielski","year":"2005","unstructured":"Ciesielski MJ, Kazim AL, Barth RF et al (2005) Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat glioma model. Cancer Immunol Immunother 54:107\u2013119","journal-title":"Cancer Immunol Immunother"},{"key":"333_CR9","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1136\/ard.2007.079137","volume":"67","author":"L Delavallee","year":"2008","unstructured":"Delavallee L, Le Buanec H, Bessis N et al (2008) Early and long-lasting protection from arthritis in tumour necrosis factor alpha (TNFalpha) transgenic mice vaccinated against TNFalpha. Ann Rheum Dis 67:1332\u20131338","journal-title":"Ann Rheum Dis"},{"key":"333_CR10","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.3748\/wjg.15.4753","volume":"15","author":"MX Dong","year":"2009","unstructured":"Dong MX, Jia Y, Zhang YB et al (2009) Emodin protects rat liver from CCl(4)-induced fibrogenesis via inhibition of hepatic stellate cells activation. World J Gastroenterol 15:4753\u20134762","journal-title":"World J Gastroenterol"},{"key":"333_CR11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0009-8981(80)90192-8","volume":"104","author":"CA Edwards","year":"1980","unstructured":"Edwards CA, O\u2019Brien WD Jr (1980) Modified assay for determination of hydroxyproline in a tissue hydrolyzate. Clin Chim Acta 104:161\u2013167","journal-title":"Clin Chim Acta"},{"key":"333_CR12","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1021\/bi00402a037","volume":"27","author":"KC Flanders","year":"1988","unstructured":"Flanders KC, Roberts AB, Ling N et al (1988) Antibodies to peptide determinants in transforming growth factor beta and their applications. Biochemistry 27:739\u2013746","journal-title":"Biochemistry"},{"key":"333_CR13","doi-asserted-by":"crossref","first-page":"d793","DOI":"10.2741\/gressner","volume":"7","author":"AM Gressner","year":"2002","unstructured":"Gressner AM, Weiskirchen R, Breitkopf K et al (2002) Roles of TGF-beta in hepatic fibrosis. Front Biosci 7:d793\u2013d807","journal-title":"Front Biosci"},{"issue":"7 Pt 1","key":"333_CR14","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1440-1746.2008.05345.x","volume":"23","author":"OA Gressner","year":"2008","unstructured":"Gressner OA, Rizk MS, Kovalenko E et al (2008) Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go? J Gastroenterol Hepatol 23(7 Pt 1):1024\u20131035","journal-title":"J Gastroenterol Hepatol"},{"key":"333_CR15","doi-asserted-by":"crossref","first-page":"20251","DOI":"10.1073\/pnas.0807200106","volume":"105","author":"C Gr\u00fctter","year":"2008","unstructured":"Gr\u00fctter C, Wilkinson T, Turner R et al (2008) A cytokine-neutralizing antibody as a structural mimetic of 2 receptor interactions. Proc Natl Acad Sci USA 105:20251\u201320256","journal-title":"Proc Natl Acad Sci USA"},{"key":"333_CR16","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1016\/j.vaccine.2009.09.058","volume":"27","author":"Q Guan","year":"2009","unstructured":"Guan Q, Ma Y, Hillman CL et al (2009) Development of recombinant vaccines against IL-12\/IL-23 p40 and in vivo evaluation of their effects in the downregulation of intestinal inflammation in murine colitis. Vaccine 27:7096\u20137104","journal-title":"Vaccine"},{"key":"333_CR17","first-page":"183","volume":"14","author":"YH Guo","year":"2006","unstructured":"Guo YH, Hao ZM, Luo JY et al (2006) Detecting the activity of antibodies induced by recombinant TGFbeta1 vaccine. Zhonghua Gan Zang Bing Za Zhi 14:183\u2013186","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"333_CR18","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3109\/00365517509095807","volume":"35","author":"HM H\u00e4kkinen","year":"1975","unstructured":"H\u00e4kkinen HM, Franssila K, Kulonen E (1975) Effect of long-term administration of ethanol to the rat: lipids, collagen and other proteins, and Mallory bodies in the liver. Scand J Clin Lab Invest 35:753\u2013765","journal-title":"Scand J Clin Lab Invest"},{"key":"333_CR19","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0168-8278(98)80073-1","volume":"29","author":"OF James","year":"1998","unstructured":"James OF, Day CP (1998) Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatol 29:495\u2013501","journal-title":"J Hepatol"},{"issue":"Suppl 3","key":"333_CR20","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1111\/j.1440-1746.2006.04584.x","volume":"21","author":"T Kisseleva","year":"2006","unstructured":"Kisseleva T, Brenner DA (2006) Hepatic stellate cells and the reversal of fibrosis. J Gastroenterol Hepatol 21(Suppl 3):S84\u2013S87","journal-title":"J Gastroenterol Hepatol"},{"key":"333_CR21","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrd2805","volume":"9","author":"M Kopf","year":"2010","unstructured":"Kopf M, Bachmann MF, Marsland BJ (2010) Averting inflammation by targeting the cytokine environment. Nat Rev Drug Discov 9:703\u2013718","journal-title":"Nat Rev Drug Discov"},{"issue":"Suppl 3","key":"333_CR22","doi-asserted-by":"crossref","first-page":"C25","DOI":"10.1016\/j.vaccine.2010.07.021","volume":"28","author":"G Leroux-Roels","year":"2010","unstructured":"Leroux-Roels G (2010) Unmet needs in modern vaccinology: adjuvants to improve the immune response. Vaccine 28(Suppl 3):C25\u2013C36","journal-title":"Vaccine"},{"key":"333_CR23","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1016\/j.vaccine.2011.03.002","volume":"29","author":"S Li","year":"2011","unstructured":"Li S, Peng L, Zhao W et al (2011) Synthetic peptides containing B- and T-cell epitope of dengue virus-2 E domain III provoked B- and T-cell responses. Vaccine 29:3695\u20133702","journal-title":"Vaccine"},{"key":"333_CR24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1478-3231.2005.01192.x","volume":"26","author":"X Liu","year":"2006","unstructured":"Liu X, Hu H, Yin JQ (2006) Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis. Liver Int 26:8\u201322","journal-title":"Liver Int"},{"key":"333_CR25","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1200\/JCO.2007.11.5980","volume":"26","author":"E Neninger Vinageras","year":"2008","unstructured":"Neninger Vinageras E, de la Torre A, Osorio Rodriguez M et al (2008) Phase II randomized controlled trial of an epidermal growth factor vaccine in advanced non-small-cell lung cancer. J Clin Oncol 26:1452\u20131458","journal-title":"J Clin Oncol"},{"key":"333_CR26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10989-009-9193-0","volume":"15","author":"SS Paramasivam Saravanan","year":"2009","unstructured":"Paramasivam Saravanan SS, Kumar D (2009) Synthesis of highly immunogenic multiple antigenic peptides for epitopes of viral antigen to use in ELISA. Int J Peptide Res Ther 15:313\u2013321","journal-title":"Int J Peptide Res Ther"},{"key":"333_CR27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.dld.2004.01.003","volume":"36","author":"M Pinzani","year":"2004","unstructured":"Pinzani M, Rombouts K (2004) Liver fibrosis: from the bench to clinical targets. Dig Liver Dis 36:231\u2013242","journal-title":"Dig Liver Dis"},{"key":"333_CR28","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.bbadis.2009.06.004","volume":"1792","author":"D Pohlers","year":"2009","unstructured":"Pohlers D, Brenmoehl J, Loffler I et al (2009) TGF-beta and fibrosis in different organs - molecular pathway imprints. Biochim Biophys Acta 1792:746\u2013756","journal-title":"Biochim Biophys Acta"},{"key":"333_CR29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00042737-200402000-00001","volume":"16","author":"FW Shek","year":"2004","unstructured":"Shek FW, Benyon RC (2004) How can transforming growth factor beta be targeted usefully to combat liver fibrosis? Eur J Gastroenterol Hepatol 16:123\u2013126","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"333_CR30","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1002\/eji.200636484","volume":"36","author":"I Sonderegger","year":"2006","unstructured":"Sonderegger I, Rohn TA, Kurrer MO et al (2006) Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis. Eur J Immunol 36:2849\u20132856","journal-title":"Eur J Immunol"},{"key":"333_CR31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/15216540400024470","volume":"57","author":"YH Song","year":"2005","unstructured":"Song YH, Zhou XM, Xue XN et al (2005) Effect of ribozyme against transforming growth factor beta1 on biological character of activated HSCs. IUBMB Life 57:31\u201339","journal-title":"IUBMB Life"},{"key":"333_CR32","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/eji.200737989","volume":"38","author":"G Spohn","year":"2008","unstructured":"Spohn G, Keller I, Beck M et al (2008) Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis. Eur J Immunol 38:877\u2013887","journal-title":"Eur J Immunol"},{"issue":"Web Server issu","key":"333_CR33","doi-asserted-by":"crossref","first-page":"W612","DOI":"10.1093\/nar\/gkp417","volume":"37","author":"J Sun","year":"2009","unstructured":"Sun J, Wu D, Xu T et al (2009) SEPPA: a computational server for spatial epitope prediction of protein antigens. Nucleic Acids Res 37(Web Server issue):W612\u2013W616","journal-title":"Nucleic Acids Res"},{"key":"333_CR34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2036.2010.04248.x","volume":"31","author":"H Szabo","year":"2010","unstructured":"Szabo H, Fiorino G, Spinelli A et al (2010) Review article: anti-fibrotic agents for the treatment of Crohn\u2019s disease - lessons learnt from other diseases. Aliment Pharmacol Ther 31:189\u2013201","journal-title":"Aliment Pharmacol Ther"},{"key":"333_CR35","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1073\/pnas.85.15.5409","volume":"85","author":"JP Tam","year":"1988","unstructured":"Tam JP (1988) Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc Natl Acad Sci USA 85:5409\u20135413","journal-title":"Proc Natl Acad Sci USA"},{"key":"333_CR36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0022-1759(96)00066-X","volume":"196","author":"JP Tam","year":"1996","unstructured":"Tam JP (1996) Recent advances in multiple antigen peptides. J Immunol Methods 196:17\u201332","journal-title":"J Immunol Methods"},{"key":"333_CR37","first-page":"565","volume":"10","author":"A Tandon","year":"2010","unstructured":"Tandon A, Tovey JC, Sharma A et al (2010) Role of transforming growth factor beta in corneal function, biology and pathology. Curr Mol Med 10:565\u2013578","journal-title":"Curr Mol Med"},{"key":"333_CR38","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1440-1746.2007.04867.x","volume":"22","author":"CT Tu","year":"2007","unstructured":"Tu CT, Guo JS, Wang M et al (2007) Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury. J Gastroenterol Hepatol 22:877\u2013884","journal-title":"J Gastroenterol Hepatol"},{"key":"333_CR39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1089\/10430340050016139","volume":"11","author":"H Ueno","year":"2000","unstructured":"Ueno H, Sakamoto T, Nakamura T et al (2000) A soluble transforming growth factor beta receptor expressed in muscle prevents liver fibrogenesis and dysfunction in rats. Hum Gene Ther 11:33\u201342","journal-title":"Hum Gene Ther"},{"key":"333_CR40","doi-asserted-by":"crossref","first-page":"18979","DOI":"10.1073\/pnas.1013387107","volume":"107","author":"TT Wang","year":"2010","unstructured":"Wang TT, Tan GS, Hai R et al (2010) Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc Natl Acad Sci USA 107:18979\u201318984","journal-title":"Proc Natl Acad Sci USA"},{"key":"333_CR41","doi-asserted-by":"crossref","first-page":"972962","DOI":"10.1155\/2013\/972962","volume":"2013","author":"G Willemin","year":"2013","unstructured":"Willemin G, Roger C, Bauduret A et al (2013) Major histocompatibility class II pathway is not required for the development of nonalcoholic fatty liver disease in mice. Int J Endocrinol 2013:972962","journal-title":"Int J Endocrinol"},{"key":"333_CR42","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jvs.2004.12.037","volume":"41","author":"RA Wolff","year":"2005","unstructured":"Wolff RA, Ryomoto M, Stark VE et al (2005) Antisense to transforming growth factor-beta1 messenger RNA reduces vein graft intimal hyperplasia and monocyte chemotactic protein 1. J Vasc Surg 41:498\u2013508","journal-title":"J Vasc Surg"},{"key":"333_CR43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-0029-1214370","volume":"29","author":"DF Wu","year":"2009","unstructured":"Wu DF, Cederbaum AI (2009) Oxidative stress and alcoholic liver disease. Semin Liver Dis 29:141\u2013154","journal-title":"Semin Liver Dis"},{"key":"333_CR44","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","volume":"214","author":"TA Wynn","year":"2008","unstructured":"Wynn TA (2008) Cellular and molecular mechanisms of fibrosis. J Pathol 214:199\u2013210","journal-title":"J Pathol"},{"key":"333_CR45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0030-1255354","volume":"30","author":"TA Wynn","year":"2010","unstructured":"Wynn TA, Barron L (2010) Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis 30:245\u2013257","journal-title":"Semin Liver Dis"},{"key":"333_CR46","first-page":"300","volume":"8","author":"W Xu","year":"2009","unstructured":"Xu W, Wang LW, Shi JZ et al (2009) Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice. Hepatobiliary Pancreat Dis Int 8:300\u2013308","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"333_CR47","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/jhep.2002.32673","volume":"35","author":"Y Yata","year":"2002","unstructured":"Yata Y, Gotwals P, Koteliansky V et al (2002) Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-beta soluble receptor: implications for antifibrotic therapy. Hepatology 35:1022\u20131030","journal-title":"Hepatology"},{"key":"333_CR48","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.taap.2007.06.013","volume":"224","author":"J Zhang","year":"2007","unstructured":"Zhang J, Wang H, Yu H (2007) Thioacetamide-induced cirrhosis in selenium-adequate mice displays rapid and persistent abnormity of hepatic selenoenzymes which are mute to selenium supplementation. Toxicol Appl Pharmacol 224:81\u201388","journal-title":"Toxicol Appl Pharmacol"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-015-0333-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-015-0333-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-015-0333-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:48:26Z","timestamp":1704228506000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-015-0333-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,5]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["333"],"URL":"https:\/\/doi.org\/10.1007\/s00005-015-0333-2","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,5]]}}}